Protagenic Therapeutics, Inc.new - COM NEW (PTIX)

Historical Portfolio Holders from Q1 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
160K
Holdings value Q2 2024
$146K
Value change Q2 2024
+$38K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
10
Number of buys Q2 2024
5
Number of sells Q2 2024
-1
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 160K $146K +$38K $0.91 10
2024 Q1 118K $206K +$19.7K $1.75 9
2023 Q4 113K $107K +$15.7K $0.99 9
2023 Q3 96.4K $179K -$2.01K $1.87 8
2023 Q2 97.2K $198K +$3.64K $2.03 9
2023 Q1 95.4K $164K +$164K $1.73 10